$69.7 Billion Oral Solid Dosage Contract Manufacturing Market Assessment 2024-2034 Featuring Lonza Group, Catalent, Recipharm
March 13, 2024 12:00 ET
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Oral Solid Dosage Contract Manufacturing Market by Product Type, by Mechanism, by End-User, and By Region" report has been added to ...
Global Oral Solid Dosage Contract Manufacturing Market 2024-2030: Regional Trends for Tablets, Capsules, Powders, and Granules
March 13, 2024 11:10 ET
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Tablets, Capsules, Powders,...
Cirtronics Highlights the Importance of Market Fit in Successful Commercialization through Panel Discussions at the 2023 & 2024 Robotics Summit and Expo
March 12, 2024 12:09 ET
|
Cirtronics
Milford, NH, March 12, 2024 (GLOBE NEWSWIRE) -- Through shared insights from four experts in the robotics industry during a panel discussion at the 2023 Robotics Summit and Expo in Boston, MA,...
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
March 06, 2024 23:58 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing...
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
March 06, 2024 16:32 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it...
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
March 06, 2024 16:31 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
February 28, 2024 16:29 ET
|
Societal CDMO, Inc.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to...
Global Aseptic Manufacturing Industry Report 2023: Biopharma Growth and Advanced Manufacturing Technologies Demand Fueling Opportunities - Forecasts to 2029
February 22, 2024 10:34 ET
|
Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Aseptic Manufacturing Market (2023 Edition): Analysis By Type (Isolators, RABS, Cleanroom Equipment), By Product Type, By Applications, By...
Global Biologics Contract Manufacturing Research Report 2022-2023 and 2023-2035: Biologics CMO Made Considerable Investments to Expand Facilities, With Some CMOs Re-evaluating Capacity Investments
February 20, 2024 04:01 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of...
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine
February 15, 2024 11:00 ET
|
Natural Alternatives International Inc
The new agreement strengthens brand expansion and distribution of a top selling ingredient in sports nutrition—CarnoSyn® beta-alanine.